# Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial

Article · Frederick Johan Raal, Narimon Honarpour, Dirk Jacobus Blom, G. Kees Hovingh, Feng Xu, Robert C. Scott, Scott M. Wasserman, Evan A. Stein

- Archive id: doi:10.1016/s0140-6736(14)61374-x
- Published: 2014-10-02
- Venue: The Lancet
- DOI: https://doi.org/10.1016/s0140-6736(14)61374-x
- PMID: 25282520
- Citations: 730
- Source URL: https://doi.org/10.1016/s0140-6736(14)61374-x
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cardiovascular Therapeutics](https://space-kitty.com/topics/cardiovascular-innovation)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.